CLINICAL_TRIALS trial_result · 2019-12-11

Clinical Trial Update: Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease [Phase 2]

Phase II study of intravenous immunoglobulin (IVIg) for Alzheimer's disease was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Weill Medical College of Cornell University | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED | Results posted: 2019-12-11